1 Anderson GL, "Wassertheil-Smoller S: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial" 291 : 1701-1712, 2004
2 Pasquali D, "Vassallo P, Bellastella A, Sinisi AA: Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease" 87 : 5125-5129, 2002
3 Ludwig M, "Use of recombinant human chorionic gonadotropin in ovulation induction" 79 : 1051-1059, 2003
4 Muratori M, "Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients" 20 : 537-546, 1997
5 van Santbrink EJ, "Urinary follicle -stimulating hormone for normogonadotropic clomiphene -resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens" 82 : 3597-3602, 1997
6 Yamagami K, "Treatment of lymphocytic hypophysitis by high-dose methylprednisolone pulse therapy" 42 : 168-173, 2003
7 Mashio Y, "Treatment of hyperthyroidism with a small single daily dose of methimazole: a prospective long-term follow-up study" 44 : 553-558, 1997
8 Trainer PJ, "Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant" 342 : 1171-1177, 2000
9 Weetman AP, "Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse" 87 : 337-341, 1994
10 Ohyama K, "Timing for discontinuation of treatment with a long-acting gonadotropin-releasing hormone analog in girls with central precocious puberty" 45 : 351-356, 1998
11 Bartter FC, "The syndrome of inappropriate secretion of antidiuretic hormone" 42 : 790-806, 1967
12 Bertagna X, "The new steroid analog RU 486 inhibits glucocorticoid action in man" 59 : 25-28, 1984
13 Pitt B, "The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators" 341 : 709-717, 1999
14 Kung AW, "The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy" 6 : 381-384, 1996
15 Meier C, "TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)" 86 : 4860-4866, 2001
16 Zelmanovitz F, "Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses" 83 : 3881-3885, 1998
17 Bilezikian JP, "Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century" 87 : 5353-5361, 2002
18 Nieman LK, "Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486" 61 : 536-540, 1985
19 Tsur A, "Successful pregnancy in a patient with pre-existing lymphocytic hypophysitis" 75 : 772-774, 1996
20 Chu JW, "Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)" 86 : 3568-3573, 2001
21 Bunim JJ, "Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties" 157 : 311-318, 1955
22 Krassas GE, "Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease" 9 : 47-52, 1999
23 Freda PU, "Somatostatin analogs in acromegaly" 87 : 3013-3018, 2002
24 Angulo M, "Sarrantonio M: Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome" 9 : 393-400, 1996
25 Tanaka T, "Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function" 1371-1376, 2005
26 Benker G, "Response to methimazole in Graves' disease. The European Multicenter Study Group" 43 : 257-263, 1995
27 Dunlop SP, "Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome" 18 : 77-84, 2003
28 Talpos GB, "Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey" 128 : 1013-1020, 2000
29 Takano K, "Psychosocial adjustment in a large cohort of adults with growth hormone deficiency treated with growth hormone in childhood: summary of a questionnaire survey. Committee for the Study Group of Adult GH Deficiency" 399 : 16-19, 1994
30 Beressi N, "Pseudotumoral lymphocytic hypophysitis successfully treated by corticosteroid alone: first case report" 35 : 505-508, 1994
31 Gwinup G, "Prospective randomized comparison of propylthiouracil" 239 : 2457-2459, 1978
32 Schleusener H, "Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease" 120 : 689-701, 1989
33 Bevan JS, "Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size" 87 : 4554-4563, 2002
34 Wada N, "Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole" 49 : 329-334, 2002
35 Pitteloud N, "Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism" 87 : 4128-4136, 2002
36 Hales I, "Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis" 29 : 998-1001, 1969
37 Davies L, "Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial" 354 : 456-460, 1999
38 Clemmons DR, "Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm" 88 : 4759-4767, 2003
39 Gerding MN, "Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy" 50 : 373-379, 1999
40 Ezzat S, "Octreotide treatment of acromegaly. A randomized, multicenter study" 117 : 711-718, 1992
41 Newman CB, "Molitch ME, Gagel RF: Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients-a clinical research center study" 80 : 2768-2775, 1995
42 Young WF Jr., "Minireview: primary aldosteronism -changing concepts in diagnosis and treatment" 144 : 2208-2213, 2003
43 Sartor O, "Mifepristone: treatment of Cushing's syndrome" 39 : 506-510, 1996
44 Spitz IM, "Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action" 329 : 404-412, 1993
45 Molitch ME, "Medical treatment of prolactinomas" 28 : 143-169, 1999
46 Hamrahian AH, "Measurements of serum free cortisol in critically ill patients" 350 : 1629-1638, 2004
47 Colao A, "Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients" 85 : 2247-2252, 2000
48 Winer KK, "Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium" 88 : 4214-4220, 2003
49 Birnbacher R, "Long-term treatment in children with hypopituitarism: pubertal development and final height" 49 : 80-85, 1998
50 Boberg KM, "Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients" 38 : 991-995, 2003
51 Takami H, "Laparoscopic adrenalectomy in asymptomatic pheochromocytoma" 63 : 820-822, 1997
52 Krassas GE, "Lanreotide in the treatment of patients with thyroid eye disease" 136 : 416-422, 1997
53 Cooper DS, "L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial" 101 : 18-24, 1984
54 Guttmann H, "Ish-Shalom S, Itskovitz-Eldor J, Aviram M, Reisner S, Hochberg Z: Choosing an oestrogen replacement therapy in young adult women with Turner syndrome" 54 : 159-164, 2001
55 Benker G, "Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs" 49 : 451-457, 1998
56 Ikeda Y, "Is laparoscopic partial or cortical-sparing adrenalectomy worthwhile?" 35 : 89-92, 2003
57 Hiromatsu Y, "Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy" 40 : 63-72, 1993
58 Notelovitz M, "Initial 17beta-estradiol dose for treating vasomotor symptoms" 95 : 726-731, 2000
59 Maison P, "Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials" 89 : 2192-2199, 2004
60 McGowan JE, Jr., "Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America" 165 : 1-13, 1992
61 van der Werff ten Bosch JJ, "Growth of males with idiopathic hypopituitarism without growth hormone treatment" 32 : 707-717, 190
62 Lindgren AC, "Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome" 158 : 936-940, 1999
63 Simpson H, "Growth hormone replacement therapy for adults: into the new millennium" 12 : 1-33, 2002
64 Carrel AL, "Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study" 134 : 215-221, 1999
65 Quigley CA, "Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height" 87 : 2033-2041, 2002
66 Olaison G, "Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation" 31 : 325-328, 1990
67 Peacey SR, "Glucocorticoid replacement therapy: are patients over treated and does it matter?" 46 : 255-261, 1997
68 Kong WM, "Finer N: A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism" 112 : 348-354, 2002
69 Hibi I, "Final height of patients with idiopathic growth hormone deficiency after long-term growth hormone treatment. Committee for Treatment of Growth Hormone Deficient Children, Growth Science Foundation" 120 : 409-415, 1989
70 Ranke MB, "Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study" 48 : 62-71, 1997
71 Barreca M, "Expectations and outcomes when moving from open to laparoscopic adrenalectomy: multivariate analysis" 27 : 223-228, 2003
72 Pollak VE, "Evaluation of treatment in lupus nephritis: effects of prednisone" 2 : 170-177, 1982
73 Larijani B, "Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial" 5 : 251-256, 1999
74 Mizukoshi T, "Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone" 40 : 292-295, 2001
75 Pitt B, "Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction" 348 : 1309-1321, 2003
76 Uzzan B, "Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis" 81 : 4278-4289, 1996
77 McGriff NJ, "Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer" 34 : 554-564, 2002
78 McConnell EM, "Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism" 56 : 195-201, 2002
79 Gambacciani M, "Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women" 185 : 1180-1185, 2001
80 Finkelstein JW, "Effects of estrogen or testosterone on self-reported sexual responses and behaviors in hypogonadal adolescents" 83 : 2281-2285, 1998
81 Castro MR, "Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis" 87 : 4154-4159, 2002
82 Ohtsuka K, "Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy" 135 : 285-290, 2003
83 Monzani F, "Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study" 86 : 1110-1115, 2001
84 al-Shoumer KA, "Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults" 4 : 85-90, 1995
85 Sawka AM, "Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial" 88 : 4551-4555, 2003
86 "Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement" 593-597, 1991
87 Padfield PL, "Demeclocycline in the treatment of the syndrome of inappropriate antidiuretic hormone release: with measurement of plasma ADH" 54 : 623-627, 1978
88 Kaplowitz P, "Delayed puberty in obese boys: comparison with constitutional delayed puberty and response to testosterone therapy" 133 : 745-749, 1998
89 Liuzzi A, "Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration" 38 : 910-912, 1974
90 Esteban NV, "Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry" 72 : 39-45, 1991
91 Coursin DB, "Corticosteroid supplementation for adrenal insufficiency" 287 : 236-240, 2002
92 Katafuchi R, "Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy" 41 : 972-983, 2003
93 Mattsson LA, "Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations" 94 : 61-65, 1999
94 "Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology" 87 : 4048-4053, 2002
95 "Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society" 85 : 3990-3993, 2000
96 "Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency" 83 : 379-381, 1998
97 Cutler GB, Jr., "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency" 323 : 1806-1813, 1990
98 Brown JJ, "Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin" 2 : 729-734, 1972
99 Kallner G, "Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease" 239 : 525-529, 1996
100 Yamamoto M, "Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?" 85 : 4583-4591, 2000
101 Romaldini JH, "Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism" 57 : 563-570, 1983
102 Okano K, "Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathy- roidism" 55 : 238-243, 1982
103 Walsh JP, "Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism" 88 : 4543-4550, 2003
104 Vitti P, "Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment" 7 : 369-375, 1997
105 Bryant J, "Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation" 6 : 115-106, 2002
106 Jackson SN, "Cabergoline treatment of acromegaly: a preliminary dose finding study" 46 : 745-749, 1997
107 Verhelst J, "Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients" 84 : 2518-2522, 1999
108 Abs R, "Cabergoline in the treatment of acromegaly: a study in 64 patients" 83 : 374-378, 1998
109 Pasquali D, "Bonavolonta G, Bellastella A, Sinisi AA: Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy" 25 : 63-71, 2000
110 Allannic H, "Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration" 70 : 675-679, 1990
111 Maugendre D, "Antithyroid drugs and Graves' disease-prospective randomized assessment of long-term treatment" 50 : 127-132, 1999
112 Garcia-Mayor RV, "Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission" 15 : 815-820, 1992
113 Chikada N, "An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid" 51 : 355-360, 2004
114 Cooper DS, "Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose" 98 : 26-29, 1983
115 Grebe SK, "A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole" 48 : 585-592, 1998
116 Papini E, "A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules" 38 : 507-513, 1993
117 Nystrom E, "A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism" 29 : 63-75, 1988
118 Bone RC, "A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock" 317 : 653-658, 1987
119 Webster J, "A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group" 331 : 904-909, 1994
120 Page SR, "A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism" 45 : 511-516, 1996
121 Imai T, "A case-controlled study of laparoscopic compared with open lateral adrenalectomy" 178 : 50-53, 1999
122 Silverberg SJ, "A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery" 341 : 1249-1255, 1999
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
KCI
